Enhanced Anti-Tumor Efficacy of Lipid-Modified Platinum Derivatives in Combination with Survivin Silencing siRNA in Resistant Non-Small Cell Lung Cancer
出版年份 2016 全文链接
标题
Enhanced Anti-Tumor Efficacy of Lipid-Modified Platinum Derivatives in Combination with Survivin Silencing siRNA in Resistant Non-Small Cell Lung Cancer
作者
关键词
chemoresistance, lipid-modified platinates, non-small cell lung cancer, small interfering RNA, <em class=EmphasisTypeItalic >survivin</em>
出版物
PHARMACEUTICAL RESEARCH
Volume 33, Issue 12, Pages 2943-2953
出版商
Springer Nature
发表日期
2016-08-16
DOI
10.1007/s11095-016-2016-z
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- MicroRNA-223 Induced Repolarization of Peritoneal Macrophages Using CD44 Targeting Hyaluronic Acid Nanoparticles for Anti-Inflammatory Effects
- (2016) Thanh-Huyen Tran et al. PLoS One
- Combinatorial-Designed Epidermal Growth Factor Receptor-Targeted Chitosan Nanoparticles for Encapsulation and Delivery of Lipid-Modified Platinum Derivatives in Wild-Type and Resistant Non-Small-Cell Lung Cancer Cells
- (2015) Ana Vanessa Nascimento et al. MOLECULAR PHARMACEUTICS
- Nanoparticle-mediated delivery of siRNA for effective lung cancer therapy
- (2015) Young-Dong Kim et al. Nanomedicine
- A new strategy in the treatment of chemoresistant lung adenocarcinoma via specific siRNA transfection of SRF, E2F1, Survivin, HIF and STAT3†
- (2014) Mircea Gabriel Stoleriu et al. EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY
- First-Line Chemotherapy Treatment of Advanced Non–Small-Cell Lung Cancer: Does Cisplatin versus Carboplatin Make a Difference?
- (2014) Marcello Tiseo et al. Journal of Thoracic Oncology
- Small RNA combination therapy for lung cancer
- (2014) W. Xue et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Molecular Mechanisms of RNA Interference
- (2013) Ross C. Wilson et al. Annual Review of Biophysics
- The Effect of Ligand Lipophilicity on the Nanoparticle Encapsulation of Pt(IV) Prodrugs
- (2013) Timothy C. Johnstone et al. INORGANIC CHEMISTRY
- In vivo biodistribution of siRNA and cisplatin administered using CD44-targeted hyaluronic acid nanoparticles
- (2013) Shanthi Ganesh et al. JOURNAL OF CONTROLLED RELEASE
- Enhanced Intrapulmonary Delivery of Anticancer siRNA for Lung Cancer Therapy Using Cationic Ethylphosphocholine-based Nanolipoplexes
- (2013) Gayong Shim et al. MOLECULAR THERAPY
- Combination of siRNA-directed Gene Silencing With Cisplatin Reverses Drug Resistance in Human Non-small Cell Lung Cancer
- (2013) Shanthi Ganesh et al. Molecular Therapy-Nucleic Acids
- Downregulation of Cyclophilin A by siRNA diminishes non-small cell lung cancer cell growth and metastasis via the regulation of matrix metallopeptidase 9
- (2012) Zhe Qian et al. BMC CANCER
- Anticancer Platinum (IV) Prodrugs with Novel Modes of Activity
- (2011) Chee Fei Chin et al. CURRENT TOPICS IN MEDICINAL CHEMISTRY
- Pt(IV) complexes as prodrugs for cisplatin
- (2011) Yi Shi et al. JOURNAL OF INORGANIC BIOCHEMISTRY
- Cisplatin as an Anti-Tumor Drug: Cellular Mechanisms of Activity, Drug Resistance and Induced Side Effects
- (2011) Ana-Maria Florea et al. Cancers
- Cancer Statistics, 2010
- (2010) A. Jemal et al. CA-A CANCER JOURNAL FOR CLINICIANS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started